Ticker Scorecard - CYCC Basics Company: Cyclacel Pharmaceuticals, Inc. IPO Date: April 1, 2004 Sector: Healthcare Industry: Biotech Market Cap: $4.73M Activated in VL: True Average Daily Range Avg Daily Range: $0.11 | 4.15% Avg Daily Range (30 D): $0.01 | 3.47% Avg Daily Range (90 D): $0.04 | 5.72% Institutional Daily Volume Avg Daily Volume: .05M Avg Daily Volume (30 D): .39M Avg Daily Volume (90 D): 1.85M Trade Size Avg Trade Size (Sh.): 48 Avg Trade Size (Sh.) (30 D): 668 Avg Trade Size (Sh.) (90 D): 443 Institutional Trades Total Inst.Trades: 38 Avg Inst. Trade: $1.11M Avg Inst. Trade (30 D): $M Avg Inst. Trade (90 D): $M Avg Inst. Trade Volume: M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.48M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: .75K     News Sep 3, 2024 @ 5:52 PM Cyclacel Pharmaceuticals May Find a Bottom Soon, H... Source: Zacks Jun 26, 2024 @ 1:15 PM Cyclacel Announces Notice of Intention to Grant Ne... Source: Cyclacel Jun 6, 2024 @ 4:00 PM All You Need to Know About Cyclacel Pharmaceutical... Source: Zacks Equity Research May 8, 2024 @ 1:15 PM Cyclacel Pharmaceuticals to Release First Quarter ... Source: Cyclacel May 2, 2024 @ 8:30 PM Cyclacel Pharmaceuticals Announces Closing of $8.0... Source: Cyclacel Financials   TTM Q3 2024 Q2 2024 Basic EPS Diluted EPS Revenue $ .07M $ .01M $ M Gross Profit $ $ $ Net Income / Loss $ -13.48M $ -1.96M $ -3.26M Operating Income / Loss $ -15.54M $ -2.18M $ -3.64M Cost of Revenue $ $ $ Net Cash Flow $ -2.91M $ M $ M PE Ratio     Splits Dec 18, 2023:   225:1 Apr 15, 2020:   20:1 May 31, 2016:   12:1 Aug 27, 2012:   7:1